CLINICAL_TRIALS
research
· 2016-03-14
Clinical Trial Update: Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients [Phase 4]
Summary
A Phase 4 study examining peripheral blood mononuclear cell gene expression in genotype 1 hepatitis C patients has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED